MSD - A quantum leap in treatment of NSCLC and HNSCC with IO (ID 62)

Time
12:45 PM - 02:15 PM

Welcome, introductions and objectives of the session (ID 1801)

The landscape and role of IO-Chemo combination in NSCLC treatment (ID 1802)

Is immuno-oncology going to replace chemotherapy in advanced HNSCC? (ID 1803)

Q&A (ID 1804)